Measuring exposure to non-tuberculous mycobacteria: defining and testing novel antigens
<p>The tuberculosis (TB) vaccine bacillus bacillus Calmette-Guerin (BCG) has low efficacy against pulmonary TB in the tropics, where most TB disease occurs, and where an effective TB vaccine is most needed. It is possible that new TB vaccines in development may be similarly affected, in partic...
| Hauptverfasser: | , |
|---|---|
| Weitere Verfasser: | |
| Format: | Abschlussarbeit |
| Sprache: | English |
| Veröffentlicht: |
2012
|
| Schlagworte: |